Accession Number: | 0001127602-23-004950 |
Date: | 2023-02-09 |
Issuer: | LEXICON PHARMACEUTICALS, INC. (LXRX) |
Original Submission Date: |
ALEXANDER KRISTEN
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
THE WOODLANDS, TX 77381
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2023-02-09 | deemed execution date | A | 47,780 (a) | common stock 47,780 | $0.00 | 47,780 | direct | |||
STOCK OPTION (RIGHT TO BUY) | 2.43 | 2023-02-09 | deemed execution date | A | 71,670 (a) | 2033-02-09 | common stock 71,670 | $2.43 | 71,670 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of common stock. |
f2 | restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on february 28 of each of the three years following the year of grant. |
f3 | option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. |